To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Dementia and Parkinson's Disease: Health Services and Social Services
Tuesday 23rd April 2024

Asked by: Peter Dowd (Labour - Bootle)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that health and social care professionals are trained in Parkinson’s-related dementia care.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.

Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.

Individual employers across health and social care are responsible for ensuring their staff are trained and competent to carry out their role, and for investing in the future of their staff by providing continuing professional development (CPD) funding. The required training needs are set out in the Dementia Training Standards Framework, which is available at the following link:

https://www.skillsforhealth.org.uk/info-hub/dementia-2015-updated-2018/

The framework was commissioned and funded by the Department, and developed in collaboration with the sector. It sets out the essential knowledge, skills, and expected learning outcomes applicable across the health and care spectrum.

It is applicable to health and social care staff who work with people living with dementia, staff providing direct care and support, and those who provide leadership in transforming care, including social care managers and leaders.

To supplement local National Health Service employer investment for CPD, the NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to continue national CPD funding for nurses, midwives, and allied health professionals. There are a variety of resources available on the NHS England e-learning for health platform, designed to enhance the training and education of the health and social care workforce. This includes a programme on dementia care, and modules in Parkinson’s disease in geriatric medicine.


Written Question
Dementia and Parkinson's Disease: Health Services and Social Services
Tuesday 23rd April 2024

Asked by: Mary Glindon (Labour - North Tyneside)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to provide training in Parkinson’s-related dementia care for health and social care professionals.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.

Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.

Individual employers across health and social care are responsible for ensuring their staff are trained and competent to carry out their role, and for investing in the future of their staff by providing continuing professional development (CPD) funding. The required training needs are set out in the Dementia Training Standards Framework, which is available at the following link:

https://www.skillsforhealth.org.uk/info-hub/dementia-2015-updated-2018/

The framework was commissioned and funded by the Department, and developed in collaboration with the sector. It sets out the essential knowledge, skills, and expected learning outcomes applicable across the health and care spectrum.

It is applicable to health and social care staff who work with people living with dementia, staff providing direct care and support, and those who provide leadership in transforming care, including social care managers and leaders.

To supplement local National Health Service employer investment for CPD, the NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to continue national CPD funding for nurses, midwives, and allied health professionals. There are a variety of resources available on the NHS England e-learning for health platform, designed to enhance the training and education of the health and social care workforce. This includes a programme on dementia care, and modules in Parkinson’s disease in geriatric medicine.


Written Question
NHS Trusts: Procurement
Tuesday 23rd April 2024

Asked by: Sarah Edwards (Labour - Tamworth)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to return NHS Trusts to pre-pandemic procurement practices.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Guidance on how contracting authorities, including National Health Service trusts, should respond to the COVID-19 pandemic was published in March 2020 and February 2021, reminding them of the options available when undertaking procurements in an emergency. These two guidance documents are available, respectively, at the following links:

https://www.gov.uk/government/publications/procurement-policy-note-0120-responding-to-covid-19

https://www.gov.uk/government/publications/procurement-policy-note-0121-procurement-in-an-emergency

Authorities are allowed to procure goods, services, and works with extreme urgency in exceptional circumstances, using regulation 32(2)(c) under the Public Contract Regulations 2015. These include a direct award under which authorities may enter into contracts without competing or advertising the requirement.

Contracting authorities assess the market conditions for procuring supplies related to any procurement, in accordance with procurement guidance and regulations. Where any procurement meets the tests for the use of Regulation 32(2)(c) for the direct awarding of a contract, then that approach can be used. However, where it doesn’t, other approaches will be considered.


Written Question
Autism: Children
Tuesday 23rd April 2024

Asked by: Fabian Hamilton (Labour - Leeds North East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to increase access to NHS assessments for Autism Spectrum Conditions for children.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

I refer the hon. Member to the answer I gave to the hon. Member for St Ives on 22 March 2024, to Question 18917.


Written Question
Hearing Impairment and Visual Impairment: Health Services
Tuesday 23rd April 2024

Asked by: Mark Hendrick (Labour (Co-op) - Preston)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure (a) blind, (b) partially sighted, (c) deaf and (d) hearing impaired patients receive (i) care and (ii) communications related to their heath in an accessible format; and if she will make an estimate of the cost to the public purse of missed appointments due to (A) inaccessible and (B) missed communications.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Under the Equality Act (2010), health and social care organisations must make reasonable adjustments to ensure that disabled people, including blind, partially sighted, deaf, and hearing impaired patients, are not disadvantaged.  Since 2016, all National Health Service organisations and publicly funded social care providers in England are required to comply with the Accessible Information Standard (AIS).

NHS England is responsible for the AIS, and have completed a review of the AIS to help ensure that the communication needs of people with a disability, impairment, or sensory loss are met in health and care provision. The AIS review included input from individuals with lived experience and voluntary sector organisations for blind, partially sighted, deaf, and hearing impaired patients.

One of the aims of the review was to strengthen assurance of implementation of the AIS, and a self-assessment framework has been developed to support providers of NHS and social care services, to measure their performance against the AIS and develop improvement action plans to address gaps in implementation. The AIS self-assessment framework is designed to enable enhancements around assurance and allows organisations, commissioners, and the Care Quality Commission (CQC) to judge performance and compliance.

NHS England will publish a revised AIS in due course. Following publication, NHS England will continue work to support its implementation with awareness raising, communication and engagement, and updated e-learning modules on the AIS to ensure NHS staff are better aware of the standard, and their roles and responsibilities in implementing it.

NHS England collects data on the total costs of missed appointments, but that data is not broken down sufficiently to enable us to make an estimate of appointments missed due to inaccessible or missed communications.


Written Question
Hospices: Children
Monday 22nd April 2024

Asked by: Ellie Reeves (Labour - Lewisham West and Penge)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she plans to issue guidance to children’s hospices on changes in the distribution of the Children’s Hospice Grant for the 2024-25 financial year.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

NHS England has confirmed it will renew the Children and Young People hospice funding for 2024/25, again allocating £25 million of funding for children’s hospices, using the same prevalence-based allocation approach as previously used. Funding will be distributed via integrated care boards (ICBs), in line with National Health Service devolution.

NHS England wrote to all ICBs and children’s hospices on 9 April 2024 to confirm the new arrangements, providing the sector with the clarity on 2024/25 allocations they have been seeking, for this very important funding stream.


Written Question
Surgery: Suffolk
Monday 22nd April 2024

Asked by: Thérèse Coffey (Conservative - Suffolk Coastal)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce waiting times for elective surgery for people in Suffolk Coastal constituency.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department plans to spend more than £8 billion from 2022/23 to 2024/25 to increase National Health Service elective activity and productivity above pre-pandemic levels, while expanding capacity through creating a new network of community diagnostic centres and maximising all available independent sector capacity.

NHS England provides robust support and challenge to the trusts which have the highest number of patients waiting the longest for elective treatment, with each receiving bespoke regional or national intervention where it is required.


Written Question
Ornithine Transcarbamylase Deficiency
Monday 22nd April 2024

Asked by: Kim Leadbeater (Labour - Batley and Spen)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to (a) support research for and (b) raise awareness of Ornithine Transcarbamylase Deficiency.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department funds research into rare diseases such as ornithine transcarbamylase deficiency through the National Institute for Health and Care Research (NIHR). Over the last five years, NIHR infrastructure has supported 13 research awards on ornithine transcarbamylase deficiency. Raising awareness of rare diseases such as ornithine transcarbamylase deficiency among healthcare professionals is a priority of the 2021 UK Rare Diseases Framework, and the 2024 England Rare Diseases Action Plan.


Written Question
Care Homes: Wellingborough
Monday 22nd April 2024

Asked by: Gen Kitchen (Labour - Wellingborough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of care homes are rated as Good by the CQC in Wellingborough constituency.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

As of 9 April 2024, the percentage of care homes in the Wellingborough Constituency with a rating of Good was 59%.


Written Question
Semaglutide: Diabetes
Monday 22nd April 2024

Asked by: Ashley Dalton (Labour - West Lancashire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from type 2 diabetes.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, the overall supply position in the United Kingdom has improved. Guidance for healthcare professionals now allows for the initiation of new patients on Rybelsus tablets, an oral semaglutide, and provides advice on what to prescribe patients who are unable to obtain their existing GLP-1 RA treatment whilst there continue to be disruptions to the supply of some products, including semaglutide. These disruptions are affecting many countries around the world, and aren’t specific to the UK.

We continue to work with international partners, given the global nature of medical supply chains, collaborating to share best practice and manage and respond to common threats to supply, including on semaglutide and other GLP-1 RAs licensed for treating patients with type 2 diabetes.